OTC drugs, prescription medications, radiopharmaceuticals, biologics, and gene therapies are all drug types. OTC pharmaceuticals, often known as non-prescription drugs, are health items available in the Canadian market that may be purchased without a medical prescription. Evidence of safety and efficacy must be supplied to Health Canada, whether it be pre-cleared information from OTC drug monographs or clinical trials.
OTC medications are regulated by Health Canada to guarantee their safety and to reduce health hazards to Canadians.
Over-the-counter (OTC), prescription medications, radiopharmaceuticals, biologics, and gene therapies are all drug types. OTC Pharmaceuticals, often known as non-prescription drugs, are health items available in the Canadian market that may be purchased without a medical prescription. Evidence of safety and efficacy must be supplied, whether it be pre-cleared information from OTC drug monographs or clinical trials undertaken on the innovative medication. OTC medications are regulated by Health Canada to guarantee their safety and to reduce health hazards to Canadians.
OTC drugs to be sold in Canada require a Drug Identification Number (DIN Number). This DIN Number on a product label indicates the drug has met all requirements for quality, safety, and efficacy. Canadian firms that are engaged in manufacturing, packaging, labeling, and importing non-prescription drugs must be licensed for these activities.
There are several monograph categories for Over-the-Counter (OTC) Drugs in Canada. These include Labeling Standard, TPD Category IV, and Non-steroidal Anti-Inflammatory Drugs (i.e. NSAIDs).
Any company (domestic or international) that manufactures, distributes, or imports OTC pharmaceuticals must provide proof that they adhere to GMP.
A mandatory requirement to fabricate (manufacture), package, label, test, import, distribute, or wholesale a finished drug or bulk process intermediate drug.
Our team of experts have licensed several different types of products, including disinfectants, cough & cold medication, allergy medication, sunscreens, and more! Some of these services include; NHP, medical devices, dietary supplements, and veterinary health products (VHP).
Our Canadian OTC Regulatory Experts are backed with extensive knowledge and years of experience. We offer OTC compliance consulting services for all types of companies to lessen the regulatory risk and assure a speedy way for the launch of your OTC drug.
A Drug Identification Number (DIN Number) is a computer-generated eight-digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN lets the user know that the product has undergone and passed a review of its formulation, labeling and instructions for use. A drug product sold in Canada without a DIN is not in compliance with Canadian law.
Through Health Canada’s Plain Language Labelling Initiative, there are new requirements for health product labelling and packaging, including a requirement for a Drug Facts Table (Facts Table) on the outer label of non-prescription drugs. The standardized format of the Drug Facts Table will help consumers find important product information quickly and easily.
The U.S. Food and Drug Administration announced on May 6, 2026, that it is piloting a new class of shorter, focused screening visits. Additionally, these
... Read more
Canada legalized recreational cannabis in 2018. However, nearly a decade later, one of the most natural extensions of that market, a licensed space where adults
... Read more
On May 12, 2026, the U.S. Food and Drug Administration finalized its new food chemical safety assessment program and simultaneously launched formal reassessments of two widely used
... Read more
Health Canada has confirmed it is moving forward with amendments to NHP labelling requirements in Canada, with draft regulations now targeted for pre-publication in the
... Read morePlease complete the form below. We will respond to you soon.
